324 related articles for article (PubMed ID: 14596938)
21. Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy.
Sensken SC; Bode C; Gräler MH
J Pharmacol Exp Ther; 2009 Mar; 328(3):963-9. PubMed ID: 19074680
[TBL] [Abstract][Full Text] [Related]
22. Hypoxic preconditioning-induced cerebral ischemic tolerance: role of microvascular sphingosine kinase 2.
Wacker BK; Park TS; Gidday JM
Stroke; 2009 Oct; 40(10):3342-8. PubMed ID: 19644058
[TBL] [Abstract][Full Text] [Related]
23. FTY720 inhibits tubulointerstitial inflammation in albumin overload-induced nephropathy of rats via the Sphk1 pathway.
Xu M; Liu D; Ding LH; Ma KL; Wu M; Lv LL; Wen Y; Liu H; Tang RN; Liu BC
Acta Pharmacol Sin; 2014 Dec; 35(12):1537-45. PubMed ID: 25399649
[TBL] [Abstract][Full Text] [Related]
24. Elimination of a hydroxyl group in FTY720 dramatically improves the phosphorylation rate.
Jary E; Bee T; Walker SR; Chung SK; Seo KC; Morris JC; Don AS
Mol Pharmacol; 2010 Oct; 78(4):685-92. PubMed ID: 20610734
[TBL] [Abstract][Full Text] [Related]
25. FTY720 (fingolimod) increases vascular tone and blood pressure in spontaneously hypertensive rats via inhibition of sphingosine kinase.
Spijkers LJ; Alewijnse AE; Peters SL
Br J Pharmacol; 2012 Jun; 166(4):1411-8. PubMed ID: 22251137
[TBL] [Abstract][Full Text] [Related]
26. Effect of alkyl chain length on sphingosine kinase 2 selectivity.
Knott K; Kharel Y; Raje MR; Lynch KR; Santos WL
Bioorg Med Chem Lett; 2012 Nov; 22(22):6817-20. PubMed ID: 22321213
[TBL] [Abstract][Full Text] [Related]
27. Activation of sphingosine kinase 2 is an endogenous protective mechanism in cerebral ischemia.
Pfeilschifter W; Czech-Zechmeister B; Sujak M; Mirceska A; Koch A; Rami A; Steinmetz H; Foerch C; Huwiler A; Pfeilschifter J
Biochem Biophys Res Commun; 2011 Sep; 413(2):212-7. PubMed ID: 21872577
[TBL] [Abstract][Full Text] [Related]
28. Sphingosine Kinase 2 Phosphorylation of FTY720 is Unnecessary for Prevention of Light-Induced Retinal Damage.
Qi H; Cole J; Grambergs RC; Gillenwater JR; Mondal K; Khanam S; Dutta S; Stiles M; Proia RL; Allegood J; Mandal N
Sci Rep; 2019 May; 9(1):7771. PubMed ID: 31123291
[TBL] [Abstract][Full Text] [Related]
29. Expression of sphingosine kinase 2 in synovial fibroblasts of rheumatoid arthritis contributing to apoptosis by a sphingosine analogue, FTY720.
Kamada K; Arita N; Tsubaki T; Takubo N; Fujino T; Soga Y; Miyazaki T; Yamamoto H; Nose M
Pathol Int; 2009 Jun; 59(6):382-9. PubMed ID: 19490468
[TBL] [Abstract][Full Text] [Related]
30. Subcellular distribution of FTY720 and FTY720-phosphate in immune cells - another aspect of Fingolimod action relevant for therapeutic application.
Schröder M; Arlt O; Schmidt H; Huwiler A; Angioni C; Pfeilschifter JM; Schwiebs A; Radeke HH
Biol Chem; 2015 Jun; 396(6-7):795-802. PubMed ID: 25720062
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylation by sphingosine kinase 2 is essential for in vivo potency of FTY720 analogues.
Högenauer K; Billich A; Pally C; Streiff M; Wagner T; Welzenbach K; Nussbaumer P
ChemMedChem; 2008 Jul; 3(7):1027-9. PubMed ID: 18383466
[No Abstract] [Full Text] [Related]
32. FTY720 inhibits tumor growth and enhances the tumor-suppressive effect of topotecan in neuroblastoma by interfering with the sphingolipid signaling pathway.
Li MH; Hla T; Ferrer F
Pediatr Blood Cancer; 2013 Sep; 60(9):1418-23. PubMed ID: 23704073
[TBL] [Abstract][Full Text] [Related]
33. The Intra-nuclear SphK2-S1P Axis Facilitates M1-to-M2 Shift of Microglia via Suppressing HDAC1-Mediated KLF4 Deacetylation.
Ji J; Wang J; Yang J; Wang XP; Huang JJ; Xue TF; Sun XL
Front Immunol; 2019; 10():1241. PubMed ID: 31214192
[TBL] [Abstract][Full Text] [Related]
34. Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury.
Jo SK; Bajwa A; Ye H; Vergis AL; Awad AS; Kharel Y; Lynch KR; Okusa MD
Kidney Int; 2009 Jan; 75(2):167-75. PubMed ID: 18971925
[TBL] [Abstract][Full Text] [Related]
35. Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720.
Kihara A; Igarashi Y
Biochim Biophys Acta; 2008 Sep; 1781(9):496-502. PubMed ID: 18555808
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors.
Raje MR; Knott K; Kharel Y; Bissel P; Lynch KR; Santos WL
Bioorg Med Chem; 2012 Jan; 20(1):183-94. PubMed ID: 22137932
[TBL] [Abstract][Full Text] [Related]
37. FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells.
Lim KG; Tonelli F; Li Z; Lu X; Bittman R; Pyne S; Pyne NJ
J Biol Chem; 2011 May; 286(21):18633-40. PubMed ID: 21464128
[TBL] [Abstract][Full Text] [Related]
38. FTY720/fingolimod, a sphingosine analogue, reduces amyloid-β production in neurons.
Takasugi N; Sasaki T; Ebinuma I; Osawa S; Isshiki H; Takeo K; Tomita T; Iwatsubo T
PLoS One; 2013; 8(5):e64050. PubMed ID: 23667698
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation of the immunomodulator FTY720 inhibits programmed cell death of fibroblasts via the S1P3 receptor subtype and Bcl-2 activation.
Potteck H; Nieuwenhuis B; Lüth A; van der Giet M; Kleuser B
Cell Physiol Biochem; 2010; 26(1):67-78. PubMed ID: 20502006
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs.
Foss FW; Mathews TP; Kharel Y; Kennedy PC; Snyder AH; Davis MD; Lynch KR; Macdonald TL
Bioorg Med Chem; 2009 Aug; 17(16):6123-36. PubMed ID: 19632123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
